EP4181920
KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENT
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.7.2021EP published:
10.9.2025EP application number:
21749550.6
EPO information:
European Patent Register
Max expiry date:
14.7.2041
Title in English:
KAT6 INHIBITOR AND COMBINATIONS FOR BREAST CANCER TREATMENTLanguage of the patent:
English
Timeline
Today
15.7.2021EP application
10.9.2025EP Publication
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Name:
CTXT PTY LTDAddress:
305 Grattan Street Parkville, Melbourne, VIC 3000, AU
Inventor
Name:
STUPPLE, Paul AnthonyAddress:
Melbourne, Victoria 3000, AU
Name:
MAZUREK, AnthonyAddress:
Flemington, NJ 08822, US
Name:
ARNDT, Kim TimothyAddress:
Chesterfield, MO 63017, US
Name:
CHEN, LeiAddress:
NY 10530, US
Name:
FOLLETTIE, Maximillian ToddAddress:
Stoneham, MA 02180, US
Name:
FRUHLING, David ScottAddress:
NY 10924, US
Name:
KUNG, Pei-PeiAddress:
San Diego, CA 92130, US
Name:
ZHONG, WenyanAddress:
NY 10956, US
Name:
TEDESCHI, Philip MichaelAddress:
Gladstone, NJ 07934, US
Priority
Number:
202063052215 PDate:
15.7.2020Country:
US
Number:
202163211044 PDate:
16.6.2021Country:
US
Classification
Categories:
A61K 31/4196, A61K 31/423, A61K 31/506, A61K 31/519, A61K 31/565, A61K 31/7064, A61K 31/18, A61K 45/06, A61P 35/00